C109 - Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies
| Event Time: | Monday May 6, 2019 3:30 pm to 5:30 pm |
| Topic(s): | Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Infectious Disease, Advanced Practice Provider, General Neurology: Overview |
| Director(s): | Ralph Jozefowicz MD, FAAN, Adam Quick MD |
| Description: | Neurology is one of the fastest changing fields in all of medicine and has differentiated into numerous well-defined complex subspecialties. These factors make it an enormous challenge to stay current. The Annual Meeting will offer four update programs each covering three unique subjects presented by a pre-eminent expert in the field who has demonstrated superior skills at delivering material of this type to large audiences. The Neurology Update courses are intended to focus on and highlight important developments in the subspecialties from the past year or two. This program complements Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease, Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology, and Neurology Update III: Headache, Neuro-otology, and Epilepsy, but covers independent topics. |
| Completion Message: | Participants should be able to apply new guidelines for acute stroke treatment, diagnose and treat the common neurological infectious diseases, and be able to recognize the clinical presentation and apply appropriate diagnostic tests for the identification of autoimmune encephalopathies. |
| CME Credits: | 2 |
| Core Competencies: |
| Start/End Time | Title | Faculty |
|---|---|---|
| 3:30 PM - 4:10 PM | Update in Stroke | Amie W. Hsia MD |
| 4:10 PM - 4:50 PM | Update in Neuro-infectious Disease | Kenneth L. Tyler MD, FAAN |
| 4:50 PM - 5:30 PM | Update in Autoimmune Encephalopathies | Steven Vernino MD, PhD, FAAN |
| Speaker | Disclosure |
|---|---|
| Amie W. Hsia, MD | Dr. Hsia has nothing to disclose. |
| Kenneth L. Tyler, MD, FAAN | Dr. Tyler has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with DNAtrix Therapeutics, and Glaxo-Smith-Kline (GSK). Dr. Tyler has received research support from Taiga Biotechnologies Inc and Anti-Plasmin Technologies. |
| Steven Vernino, MD, PhD, FAAN | Dr. Vernino has received research support from Genentech, Grifols, Quest Diagnostics, Theravance, BioHaven, Dysautonomia International, Rex Griswold Foundation and the Fichtenbaum Trust. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C245 -
Controversies in Stroke Treatment and Prevention
Pierre Fayad MD, FAAN, FAHA |
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 11:45 AM-12:45 PM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
S57 -
Acute Treatment and Imaging of Ischemic Stroke
|
| 3:30 PM-4:30 PM |
|
C256 -
Education Blitz: Emerging Infectious Diseases of the Central Nervous System
Avindra Nath MD, MBBS, FAAN |
|
C257 -
Education Blitz: Evolution of Autoimmune Neurology
Steven Vernino MD, PhD, FAAN |